Catalent Indiana, LLC

Form 483 issued April 24, 2026 · Bloomington, Indiana

Inspection
Apr 13 – Apr 24, 2026
Observations
1
Pages
15
FEI number
3005949964

In short: On April 24, 2026, FDA issued a Form 483 with 1 observation to Catalent Indiana, LLC in Bloomington, Indiana (FEI 3005949964) after an inspection that ran Apr 13 – Apr 24, 2026. The investigators were Brandy N. Lepage, Joohi Castelvetere and Robert J. Ham. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written records of investigations into the failure of a batch or any of its components to…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Catalent Indiana, LLC?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Catalent Indiana, LLC?

Brandy N. Lepage, Joohi Castelvetere and Robert J. Ham are named on this Form 483, for the inspection of Apr 13 – Apr 24, 2026. Each investigator has a profile showing what they cite most.

When was Catalent Indiana, LLC inspected by FDA?

The inspection ran Apr 13 – Apr 24, 2026, and the Form 483 is dated April 24, 2026.

How do I get the full Form 483 for Catalent Indiana, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free